News Article
Apr 5, 2019
ReViral to present at Microbiology Society Annual Conference 2019

ReViral's Chief Scientific Officer, Stuart Cockerill, will be giving an oral presentation at the Microbiology Society Annual Conference 2019 (8th-11th April) in Belfast. The presentation entitled "Design, identification and clinical progression of RV521, an inhibitor of respiratory syncytial virus fusion" begins at 10:00am on Wednesday 10th April.